Transplantation |

The Role of Home Spirometry Monitoring of FEV1 in Early Detection of Acute Rejection and Other Adverse Events in Lung Transplant Patients FREE TO VIEW

Kanae Mukai*, MD; Cassie Kennedy, MD; Darrell Schroeder, MS; Carl Mottram, RRT; Kenneth Parker, BS; John Scott, MD; Sheila Alrick, CPFT; Andrew Hanson, BS; Paul Scanlon, MD
Author and Funding Information

Mayo Clinic, Scottsdale, AZ

Chest. 2012;142(4_MeetingAbstracts):1091A. doi:10.1378/chest.1386687
Text Size: A A A
Published online


SESSION TYPE: Lung Transplantation

PRESENTED ON: Monday, October 22, 2012 at 11:15 AM - 12:30 PM

PURPOSE: We sought to determine the correlation between a decline in FEV1 and subsequent rejection, pneumonia, or infection in patients enrolled in a home spirometry monitoring program.

METHODS: With approval of the Mayo Clinic IRB, we retrospectively reviewed records of 89 consenting consecutive lung transplant recipients (single, double, or heart-lung) from 9/26/02 until 6/12/10. We excluded those who survived less than 3 months post-transplant. All episodes of lung allograft rejection (ISHLT Grades A through D) and pneumonia (biopsy-proven and clinically diagnosed) were recorded as separate clinical events. For patients who experienced multiple events of a given type, we analyzed the time to the first event. We estimated the cumulative percentage of patients who experienced events using the Kaplan-Meier method. To assess whether a decline in FEV1 was predictive of a subsequent rejection event, we performed a proportional hazards regression analysis using the decline in FEV1 modeled as a non-reversible binary time dependent covariate.

RESULTS: Decline in FEV1 was associated with ISHLT Grade B rejection (hazard ratio = 2.98, 95% C.I. 0.99-8.93, p=0.052). Curiously, the association of FEV1 decline with ISHLT Grade A rejection demonstrated a hazard ratio of 0.48 (95% C.I. 0.26-1.03, p=0.062). The association with clinically diagnosed pneumonia was small and not statistically significant (hazard ratio = 1.26, 95% C.I. 0.50-3.18, p=0.630). We found no association with other rejection grades, organizing pneumonia, or infection. At 5 years, 56% (95% C.I. 40-67%), 36% (95% C.I. 20-49%), and 29% (95% C.I. 16-40%) of patients experienced 1 or more episodes of rejection, ISHLT Grade A or Grade B, or pneumonia (clinically diagnosed), respectively.

CONCLUSIONS: A decline in FEV1 facilitates diagnosis of ISHLT Grade B rejection. The lack of a predictive relationship between FEV1 and other ISHLT grades is unexplained by our data. A positive correlation with a clinical diagnosis of pneumonia was suggested.

CLINICAL IMPLICATIONS: A home spirometry program may facilitate early detection and treatment of acute lung rejection, thus helping to prevent irreversible graft injury.

DISCLOSURE: The following authors have nothing to disclose: Kanae Mukai, Cassie Kennedy, Darrell Schroeder, Carl Mottram, Kenneth Parker, John Scott, Sheila Alrick, Andrew Hanson, Paul Scanlon

No Product/Research Disclosure Information

Mayo Clinic, Scottsdale, AZ




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543